- Bedoelde u
- risk
Zoekresultaten - 10 results
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
can be triaged accurately with a high-risk human papillomavirus (hrHPV) test to identify those who need a referral. However, the triage of low-grade squamous intraepithelial lesion (LSIL) with hrHPV ...
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
Volume 125, Issue 2 (2019) Keywords: Adult Case-Control Studies Female Follow-Up Studies Human papillomavirus 16 Human papillomavirus 18 Humans middle aged Papillomaviridae Papillomavirus Infections Risk ...
The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer
with competing risks using the Fine and Gray model; we will also perform a multistate model using transitions probabilities; and finally, a group-based modeling for longitudinal data using the ‘proc ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
as Topic Sensitivity and Specificity specimen handling Uterine Cervical Dysplasia Uterine Cervical Neoplasms Vagina Vaginal Smears Abstract: OBJECTIVE: To evaluate the diagnostic accuracy of high-risk ...
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
those associated with vaccine HPV types and any cervical precancer. Exposure groups were: women aged: 15-26 or 24-45 years being initially negative for high-risk HPV (hrHPV) or negative for the vaccine ...
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Guidelines as Topic Reproducibility of Results Sensitivity and Specificity Uterine Cervical Neoplasms Abstract: BACKGROUND Cervical cancer screening with assays detecting DNA of high-risk human papillomavirus ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
assays are foreseen to be evaluated: RealTime High Risk HPV assay (Abbott), cobas-4800 and-6800 (Roche), Onclarity (BD), Xpert HPV (Cepheid) and Anyplex II HPV HR (Seegene). CONCLUSION: Given empirical ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
assessment, we considered it as high-risk (hr) HPV positive when at least one of the following HPV types was present: HPV16, HPV18, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV56, HPV58, HPV59, and ...
Early effects of human papillomavirus vaccination in Belgium.
participating in opportunistic cervical cancer screening. A significant reduction in the prevalence of HPV 16 [relative risk (RR)=0.61, 95% confidence interval=0.39-0.95] and a nonsignificant reduction in HPV 18 ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
+/6+ PCR, with a genotyping readout as an alternative for the more established enzyme immunoassay (EIA) detection of 14 targeted high-risk human papillomavirus (HPV) types. LMNX is additionally provided ...